Alzheimer’s Disease: Biosciences Leads the Way with Research & Development
We have all experienced the worry and panic of losing our car keys or that important document, or the frustration when you can’t remember the one item you went to the shop to buy but imagine what it would be like to experience this stress on a daily basis. This is what a dementia sufferer has to endure regularly as part of their normal lives.
Alzheimer’s disease, the most common form of Dementia, is a debilitating disease affecting the brain causing memory loss and difficulties with thinking, problem solving or language.
During the course of the disease, the chemistry and structure of the brain changes, leading to the death of nerve cells and brain tissue.
As the disease progresses daily life can be massively impacted as the person may experience some or all of the below symptoms:
- Forgetting appointments or important dates
- Loosing items such as keys
- Struggling to find the right words in conversation
- Forgetting conversations
- Difficulty judging distance resulting in problems navigating stairs or driving
- Difficulty concentrating and planning or carrying out daily tasks
- Loosing track of time or whereabouts
A staggering one in six people aged 80 and over has dementia, a growing concern in the ageing population and it is estimated that there will be 1 million people with dementia in the UK by 2025.*
Unfortunately Dementia is progressive which means symptoms gradually get worse as the illness develops, however early diagnosis can significantly improve the quality of life for sufferers as well as supporting friends and family through dealing with the difficult symptoms.
Currently only 44% of people with dementia in England, Wales and Northern Ireland receive a diagnosis.* Often symptoms do not occur until the disease has progressed and can be taken as general forgetfulness and overlooked.
Due to late diagnosis sufferers can often endure periods of additional stress and confusions over what is happening to them causing worry and upset for suffers and those close to them.
Treatment for Alzheimer’s disease does exist and can help reduce some of the symptoms associated and early indication of risk of developing Alzheimer’s can also help manage the impact of the disease.
Our Cerebral Arrays have been designed for the simultaneous measurement of analytes associated with nervous system dysfunctions such as Alzheimer’s disease utilizing our multiplex testing from a single sample and can help identify nervous system disorders.
We at Randox are dedicated to research and development of new products to improve the lives of patients globally. Our skilled research and development teams are currently working hard to progress Alzheimer’s diagnosis with our innovative and cutting edge clinical technology. We see a better future for Alzheimer’s on the horizon.
Connect with us to keep informed of our world leading new research and products on Twitter and LinkedIn.
*Alzheimer’s Org UK